Pharma

sponsor

Topics in Pharma

Conferences/Meetings

Drug/Product Approvals

Execs on the Move

Financial Reports

M&A/Partnerships

Marketing/Media/ROI

Medical Devices/Products

Physician/Patient Trends

Regulatory Issues

Research & Development

Become a Member Today!
Register

Most Viewed Abstracts

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

XenoPort Announces Proposed Public Offering of Common Stock
XenoPort, 07/22/09

XenoPort, Inc. announced that it is offering to sell, subject to market and other conditions, 2,500,000 shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. XenoPort also intends to grant the underwriters a 30–day option to purchase up to an aggregate of 375,000 additional shares of common stock to cover over–allotments, if any. All of the shares in the offering are to be sold by XenoPort.

<< Previous
Merck Announces Second-Quarter 2009 Financial Results

Next >>
FDA to Get Tougher

Related Articles

GlaxoSmithKline and XenoPort announce extension of GSK1838262 FDA review date to 2010
GlaxoSmithKline, 11/10/09 Relevance Score: 84%

XenoPort to Release Third Quarter Financial Results on November 2009
XenoPort, 10/30/09 Relevance Score: 84%

XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease
XenoPort, 10/20/09 Relevance Score: 84%

Positive Phase II Results for GSK1838262 Reported for Subjects with Post-Herpetic Neuralgia and a History of Inadequate Response to Gabapentin
XenoPort, 10/06/09 Relevance Score: 80%

Positive phase II results for GSK1838262 reported for subjects with post-herpetic neuralgia and a history of inadequate response to gabapentin
GlaxoSmithKline, 10/06/09 Relevance Score: 80%

Today in Financial Reports...keeping you current

Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09

Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering
Dendreon Coproration, 12/15/09

Pre-Budget Report response - GSK comments on patent box
GlaxoSmithKline, 12/11/09

See all of Financial Reports

Today in Marketing/Media/ROI...keeping you current

Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09

Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09

Mediware Makes Two Buys
HealthDataManagement, 12/10/09

See all of Marketing/Media/ROI

Article Search

Sponsor

Send this Summary to a Colleague